MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,667 | +42.5% | 2,724,226 | +18.2% | 5.09% | +97.1% |
| Q2 2023 | $83,287 | +45.7% | 2,305,181 | +49.9% | 2.58% | -24.0% |
| Q1 2023 | $57,172 | -45.9% | 1,537,709 | -34.1% | 3.40% | -42.4% |
| Q4 2022 | $105,697 | -99.9% | 2,332,758 | +76.1% | 5.90% | +49.4% |
| Q3 2022 | $92,538,000 | +25.3% | 1,325,000 | +20.5% | 3.95% | +0.1% |
| Q2 2022 | $73,843,000 | -33.5% | 1,100,000 | -18.5% | 3.94% | -15.1% |
| Q1 2022 | $110,997,000 | -46.0% | 1,350,000 | -3.6% | 4.65% | -16.6% |
| Q4 2021 | $205,366,000 | -3.3% | 1,400,000 | +16.7% | 5.57% | +17.3% |
| Q3 2021 | $212,292,000 | +54.6% | 1,200,000 | +41.2% | 4.75% | +70.4% |
| Q2 2021 | $137,301,000 | +10.6% | 850,000 | +17.2% | 2.79% | +27.0% |
| Q1 2021 | $124,193,000 | +13.1% | 725,000 | +45.0% | 2.19% | -7.0% |
| Q4 2020 | $109,820,000 | +32.3% | 500,000 | 0.0% | 2.36% | +17.0% |
| Q3 2020 | $83,025,000 | +432.8% | 500,000 | +150.0% | 2.02% | +222.6% |
| Q3 2019 | $15,582,000 | +0.9% | 200,000 | +33.3% | 0.62% | 0.0% |
| Q2 2019 | $15,450,000 | +20.4% | 150,000 | -14.3% | 0.62% | +19.3% |
| Q1 2019 | $12,828,000 | +602.9% | 175,000 | +75.0% | 0.52% | +1771.4% |
| Q4 2017 | $1,825,000 | -5.3% | 100,000 | +63.2% | 0.03% | -66.3% |
| Q2 2015 | $1,928,000 | -73.7% | 61,276 | -75.5% | 0.08% | -75.5% |
| Q1 2015 | $7,330,000 | +58.3% | 250,000 | 0.0% | 0.34% | +109.3% |
| Q4 2014 | $4,630,000 | +5.8% | 250,000 | 0.0% | 0.16% | +0.6% |
| Q3 2014 | $4,378,000 | -12.4% | 250,000 | 0.0% | 0.16% | -20.3% |
| Q2 2014 | $5,000,000 | +4.9% | 250,000 | 0.0% | 0.20% | +16.8% |
| Q1 2014 | $4,768,000 | +63.8% | 250,000 | +42.9% | 0.17% | +66.3% |
| Q4 2013 | $2,910,000 | – | 175,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |